RNLX - חוב כולל להון Renalytix plc

The historical price dynamics for the separate_debt_total_eq metric for Renalytix Plc (RNLX) stand at 0.00. The business relies on the KidneyIntelX cloud AI service, where software-based biomarker analysis enables the scaling of diagnostics to millions of people without increasing costs. Partnerships with hospitals are accelerating the implementation of the early pathology detection system. However, slow insurance coverage and the risk of funding shortages are forcing the company to optimize its budget.

This ratio determines the degree of the business's dependence on borrowed funds relative to equity, signaling default risks in the event of rising rates or market stagnation. By analyzing the debt-to-equity level, an investor assesses the financial stability of Renalytix Plc during the scaling of KidneyIntelX and the implementation of an AI system for settlements with insurance companies.